Jean-Marie REIMUND

PUPH

ORCID – ResearcherID

(+33)

 

 

 

Liste des publications :

 

Bouguen, G., Huguet, A., Amiot, A., Viennot, S., Cholet, F., Nachury, M., … GETAID group. (2019). Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn’s Disease. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association. https://doi.org/10.1016/j.cgh.2019.05.027
Caron, B., Peyrin-Biroulet, L., Pariente, B., Bouhnik, Y., Seksik, P., Bouguen, G., … GETAID. (2019). Vedolizumab therapy is ineffective for primary sclerosing cholangitis in patients with inflammatory bowel disease: A GETAID multicentre cohort study. Journal of Crohn’s & Colitis. https://doi.org/10.1093/ecco-jcc/jjz088
Balbinot, C., Vanier, M., Armant, O., Nair, A., Penichon, J., Soret, C., … Freund, J.-N. (2017). Fine-tuning and autoregulation of the intestinal determinant and tumor suppressor homeobox gene CDX2 by alternative splicing. Cell Death and Differentiation, 24(12), 2173–2186. https://doi.org/10.1038/cdd.2017.140
Reimund, J.-M., & Freund, J.-N. (2017). Inflammatory Bowel Disease-associated Cancer. In M. Schwab (Ed.), Encyclopedia of Cancer (pp. 2256–2263). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-46875-3_3046
Berdugo, Y., Ngimpi-Tambou, M., Delhorme, J.-B., Besch, C., Brigand, C., Rohr, S., … Reimund, J.-M. (2016). Prise en charge des fistules périanales dans la maladie de Crohn. Hépato-Gastro & Oncologie Digestive, 23(4), 335–344. https://doi.org/10.1684/hpg.2016.1284
Freund, J.-N., Duluc, I., Reimund, J.-M., Gross, I., & Domon-Dell, C. (2015). Extending the functions of the homeotic transcription factor Cdx2 in the digestive system through nontranscriptional activities. World Journal of Gastroenterology, 21(5), 1436–1443. https://doi.org/10.3748/wjg.v21.i5.1436
Abdallah Hajj Hussein, I., Freund, J. N., Reimund, J. M., Shams, A., Yamine, M., Leone, A., & Jurjus, A. R. (2012). Enteropathogenic e.coli sustains iodoacetamide-induced ulcerative colitis-like colitis in rats: modulation of IL-1β, IL-6, TNF-α, COX-2, and apoptosisi. Journal of Biological Regulators and Homeostatic Agents, 26(3), 515–526.
Reimund, J.-M., Tavernier, M., Viennot, S., Hussein, I. A. H., Dupont, B., Justum, A.-M., … Lechevrel, M. (2012). Ulcerative Colitis-Associated Colorectal Cancer Prevention by 5-Aminosalicylates: Current Status and Perspectives. https://doi.org/10.5772/25577
Laurent, C., Svrcek, M., Flejou, J.-F., Chenard, M.-P., Duclos, B., Freund, J.-N., & Reimund, J.-M. (2011). Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer. Inflammatory Bowel Diseases, 17(1), 232–240. https://doi.org/10.1002/ibd.21451
Reimund, J.-M., & Freund, J.-N. (2008). Inflammatory Bowel Disease-associated Cancer. In M. Schwab (Ed.), Encyclopedia of Cancer (pp. 1525–1528). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-47648-1_3046